Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 4
1965 1
1966 2
1967 4
1968 3
1969 4
1970 2
1971 3
1972 1
1973 2
1974 2
1975 1
1976 2
1977 1
1978 2
1979 1
1980 3
1981 1
1982 2
1983 1
1984 5
1985 4
1987 1
1988 1
1989 1
1990 1
1991 2
1992 4
1993 3
1994 5
1995 6
1996 5
1997 7
1998 10
1999 3
2000 6
2001 2
2002 4
2004 2
2005 4
2006 5
2007 7
2008 13
2009 13
2010 9
2011 13
2012 21
2013 23
2014 11
2015 15
2016 19
2017 28
2018 26
2019 18
2020 24
2021 30
2022 17
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

378 results

Results by year

Filters applied: . Clear all
Page 1
Tissue hydraulics in reproduction.
Chan CJ, Hirashima T. Chan CJ, et al. Among authors: hirashima t. Semin Cell Dev Biol. 2022 Nov;131:124-133. doi: 10.1016/j.semcdb.2022.05.008. Epub 2022 May 21. Semin Cell Dev Biol. 2022. PMID: 35606275 Review.
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component.
Yang JC, Ahn MJ, Kim DW, Ramalingam SS, Sequist LV, Su WC, Kim SW, Kim JH, Planchard D, Felip E, Blackhall F, Haggstrom D, Yoh K, Novello S, Gold K, Hirashima T, Lin CC, Mann H, Cantarini M, Ghiorghiu S, Jänne PA. Yang JC, et al. Among authors: hirashima t. J Clin Oncol. 2017 Apr 20;35(12):1288-1296. doi: 10.1200/JCO.2016.70.3223. Epub 2017 Feb 21. J Clin Oncol. 2017. PMID: 28221867 Free article. Clinical Trial.
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G).
Yamazaki K, Nagase M, Tamagawa H, Ueda S, Tamura T, Murata K, Eguchi Nakajima T, Baba E, Tsuda M, Moriwaki T, Esaki T, Tsuji Y, Muro K, Taira K, Denda T, Funai S, Shinozaki K, Yamashita H, Sugimoto N, Okuno T, Nishina T, Umeki M, Kurimoto T, Takayama T, Tsuji A, Yoshida M, Hosokawa A, Shibata Y, Suyama K, Okabe M, Suzuki K, Seki N, Kawakami K, Sato M, Fujikawa K, Hirashima T, Shimura T, Taku K, Otsuji T, Tamura F, Shinozaki E, Nakashima K, Hara H, Tsushima T, Ando M, Morita S, Boku N, Hyodo I. Yamazaki K, et al. Among authors: hirashima t. Ann Oncol. 2016 Aug;27(8):1539-46. doi: 10.1093/annonc/mdw206. Epub 2016 May 13. Ann Oncol. 2016. PMID: 27177863 Free article. Clinical Trial.
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.
Mitsudomi T, Morita S, Yatabe Y, Negoro S, Okamoto I, Tsurutani J, Seto T, Satouchi M, Tada H, Hirashima T, Asami K, Katakami N, Takada M, Yoshioka H, Shibata K, Kudoh S, Shimizu E, Saito H, Toyooka S, Nakagawa K, Fukuoka M; West Japan Oncology Group. Mitsudomi T, et al. Among authors: hirashima t. Lancet Oncol. 2010 Feb;11(2):121-8. doi: 10.1016/S1470-2045(09)70364-X. Epub 2009 Dec 18. Lancet Oncol. 2010. PMID: 20022809 Clinical Trial.
Editorial: Multicellularity: Views from cellular signaling and mechanics.
Hirata H, Nakazawa N, Hirashima T, Ravasio A. Hirata H, et al. Among authors: hirashima t. Front Cell Dev Biol. 2023 Mar 13;11:1172921. doi: 10.3389/fcell.2023.1172921. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 36994099 Free PMC article. No abstract available.
Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancer.
Masuhiro K, Tamiya M, Fujimoto K, Koyama S, Naito Y, Osa A, Hirai T, Suzuki H, Okamoto N, Shiroyama T, Nishino K, Adachi Y, Nii T, Kinugasa-Katayama Y, Kajihara A, Morita T, Imoto S, Uematsu S, Irie T, Okuzaki D, Aoshi T, Takeda Y, Kumagai T, Hirashima T, Kumanogoh A. Masuhiro K, et al. Among authors: hirashima t. JCI Insight. 2022 May 9;7(9):e157915. doi: 10.1172/jci.insight.157915. JCI Insight. 2022. PMID: 35389889 Free PMC article.
378 results